The Food and Drug Administration on Tuesday approved the world’s first drug aimed at increasing women’s sex drives after rejecting it twice previously.
The drug is flibanserin and will be marketed as Addyi to treat Hypoactive Sexual Desire Disorder. The FDA report warned of the possibility of low blood pressure and fainting if patients drink alcohol while taking the drug.
The FDA is requiring the drug manufacturer Sprout Pharmaceuticals to undertake three studies to better understand the effects of alcohol on women taking the libido pill.
Supporters say the drug gives women more control over their sex lives and corrects a “gender bias,” since men have had sexual enhancement drugs such as Viagra for years. Critics contend it turns a normal condition of women’s low sexual desire into a disease.